Pfizer and MNHS strategic alliance for the discovery of new therapeutics
Monash Medicine, Nursing and Health Sciences was the first non-USA-based entity to join Pfizer’s Centers for Therapeutic Innovation (CTI). The CTI is a unique academic-industry collaboration model which is designed to bridge the gap between early scientific discovery and its translation into new medicines and therapies.
Together, Pfizer and Monash are working to create new therapies for cancer and fibrosis.
Pfizer has benefited from the partnership by gaining access to world-leading science and novel therapeutic targets, while Monash has gained exposure to the industry translation and research and development process.